Harvard Bioscience - 15 Year Stock Price History | HBIO
Historical daily share price chart and data for Harvard Bioscience since 2011 adjusted for splits and dividends. The latest closing stock price for Harvard Bioscience as of June 09, 2026 is 6.04.
- The all-time high Harvard Bioscience stock closing price was 84.70 on August 12, 2021.
- The Harvard Bioscience 52-week high stock price is 9.40, which is 55.6% above the current share price.
- The Harvard Bioscience 52-week low stock price is 3.75, which is 37.9% below the current share price.
- The average Harvard Bioscience stock price for the last 52 weeks is 5.50.
| Harvard Bioscience Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 5.7540 | 6.5190 | 7.2400 | 4.3100 | 6.0400 | -9.69% |
| 2025 | 6.8416 | 20.3000 | 21.9000 | 2.8430 | 6.6880 | -68.30% |
| 2024 | 32.9677 | 53.9000 | 53.9000 | 19.8000 | 21.1000 | -60.56% |
| 2023 | 43.9682 | 26.8000 | 61.6000 | 24.5000 | 53.5000 | 93.14% |
| 2022 | 40.3803 | 71.4000 | 71.4000 | 21.2000 | 27.7000 | -60.71% |
| 2021 | 67.7310 | 42.2000 | 84.7000 | 39.1000 | 70.5000 | 64.34% |
| 2020 | 31.2966 | 30.5000 | 45.0000 | 14.2000 | 42.9000 | 40.66% |
| 2019 | 29.7185 | 32.0000 | 45.9000 | 15.9000 | 30.5000 | -4.09% |
| 2018 | 47.9359 | 33.0000 | 66.5000 | 30.3000 | 31.8000 | -3.64% |
| 2017 | 29.2211 | 29.0000 | 38.0000 | 23.0000 | 33.0000 | 8.20% |
| 2016 | 28.3518 | 32.3000 | 38.3000 | 23.0000 | 30.5000 | -12.10% |
| 2015 | 47.7321 | 54.9000 | 67.0000 | 28.7000 | 34.7000 | -38.80% |
| 2014 | 45.3032 | 47.5000 | 56.7000 | 37.3000 | 56.7000 | 20.64% |
| 2013 | 40.2732 | 33.7915 | 50.7000 | 32.5035 | 47.0000 | 41.63% |
| 2012 | 30.0942 | 30.0032 | 34.2461 | 26.5180 | 33.1854 | 13.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |